Prakt. lékáren. 2020; 16(1): 12-16 | DOI: 10.36290/lek.2020.002

Probiotics in gynaecology

Petr Jílek1, Daniel Leško2, Jan Kestřánek2
1 Farmaceutická fakulta UK Hradec Králové
2 Porodnická a gynekologická klinika FN Hradec Králové

Probiotics are preparations containing live microorganisms designed to therapeutic and preventive effect on the microbiome, immunity, metabolism and other properties of the person taking them. The role of probiotics, including "gynecological", is to integrate into the ecosystem and change its properties (ideally restore eumicrobia) for at least some time, in a situation where the patient is subjected to vulvovaginal dyscomfort as a consequence of vaginal dysmicrobia caused by various influences (including hormonal contraceptives, personal hygiene, diet, dressing, antibiotics, sex). The composition of individual microbiota shows diversity, so it is not possible to assume that a universal probiotic strain will be found. It can be expected that some preparation will help some patient, others will not. The spectrum of probiotic preparations is still narrow, it can be expected to expand and in addition to refine the indications based on the characterization of the patient's microbiome and the choice of a compatible probiotic strain.

Keywords: probiotics, dysmicrobia, vulvovaginal dyscomfort, therapy.

Published: March 20, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jílek P, Leško D, Kestřánek J. Probiotics in gynaecology. Praktické lékárenství. 2020;16(1):12-16. doi: 10.36290/lek.2020.002.
Download citation

References

  1. Gomez A, Petrzelkova KJ, Burns MB, Yeoman CJ, Amato KR, Vlckova K, et al. Gut Microbiome of Coexisting BaAka Pygmies and Bantu Reflects Gradients of Traditional Subsistence Patterns. Cell Rep. 2016; 14: 2142-2153. Go to original source... Go to PubMed...
  2. Rook GA. Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis. 2011; 29: 144-153. Go to original source... Go to PubMed...
  3. Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014; 289: 479-489. Go to original source...
  4. Špaček J, Buchta V, Jílek P et al. Vulvovaginální dyskomfort a poruchy poševního prostředí. Praha: Grada; 2013.
  5. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011; 108 Suppl 1: 4680-4687. Go to original source... Go to PubMed...
  6. Reid G, Dols J, Miller W. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care. 2009; 12: 583-587. Go to original source...
  7. Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Investig Allergol Clin Immunol. 2004; 38(6 Suppl): S107-110. Go to original source...
  8. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006; 24: 28-32. Go to original source...
  9. Lee Y. Characterization of Weissella kimchii PL9023 as a potential probiotic for women. FEMS Microbiol Lett. 2005; 250: 157-162. Go to original source... Go to PubMed...
  10. Huang H, Song L, Zhao W. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch Gynecol Obstet. 2014; 289: 1225-1234. Go to original source...
  11. Wagner RD, Johnson SJ. Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci. 2012; 19: 58. Go to original source...
  12. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Candido RC, Ferreira JC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009; 48: 269-274. Go to original source...
  13. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R a spol. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35: 131-134. Go to original source...
  14. Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X a spol. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database Syst Rev. 2017; 11: CD010496. Go to original source...
  15. Bohbot JM, Darai E, Bretelle F, Brami G, Daniel C a Cardot JM. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod. 2018; 47: 81-86. Go to original source...
  16. Jurden L, Buchanan M, Kelsberg G, Safranek S. Clinical Inquiry: Can probiotics safely prevent recurrent vaginitis? J Fam Pract. 2012; 61: 357-368.
  17. Gabrielli E, Pericolini E, Ballet N, Roselletti E, Sabbatini S, Mosci P, et al. Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis. Benef Microbes. 2018; 9: 219-230. Go to original source... Go to PubMed...
  18. Mezzasalma V, Manfrini E, Ferri E, Boccarusso M, Di Gennaro P, Schiano I, et al. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study. Arch Gynecol Obstet. 2017; 295: 163-172. Go to original source...
  19. DeLong K, Bensouda S, Zulfiqar F, Zierden HC, Hoang TM, Abraham AG, et al. Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant. Frontiers in cellular and infection microbiology. 2019; 9: 306. Go to original source... Go to PubMed...
  20. Patrignani F, Siroli L, Parolin C, Serrazanetti DI, Vitali B, Lanciotti R. Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections. PLoS One. 2019; 14: e0208906. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.